KALA BIO, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $3.9M | $11.2M |
| Operating income | -$39.2M | -$41.0M | -$39.7M | -$81.7M | -$130.2M |
| Operating expenses | $39.2M | $41.0M | $39.7M | $85.6M | $141.5M |
| Cash from operations | -$32.0M | -$29.4M | -$27.9M | -$78.9M | -$108.2M |
| Impairments | $549,000 | $0 | $0 | — | — |
| Total assets | $9.5M | $55.5M | $55.9M | $86.8M | $139.4M |
| Total liabilities | $2.5M | $43.2M | $48.4M | $67.8M | $122.6M |
Shares outstanding 18.6M · Free float 58.2%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.